Probability of IV Antibiotic Retreatment within Thirty Days is Associated with Duration and Location of IV Antibiotic Treatment for Pulmonary Exacerbation in Cystic Fibrosis

Lignende værker

• IV-Treated Pulmonary Exacerbations in the Prior Year: An Important Independent Risk Factor for Future Pulmonary Exacerbation in Cystic Fibrosis
  af: VanDevanter, Donald R., et al.
  Udgivet: (2015)
• Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
  af: VanDevanter, Donald R, et al.
  Udgivet: (2010)
• Oral, Inhaled, and Intravenous Antibiotic Choice for Treating Pulmonary Exacerbations in Cystic Fibrosis
  af: Wagener, Jeffrey S., et al.
  Udgivet: (2012)
• TREATMENT AND DEMOGRAPHIC FACTORS AFFECTING TIME TO NEXT PULMONARY EXACERBATION IN CYSTIC FIBROSIS
  af: VanDevanter, Donald R., et al.
  Udgivet: (2015)
• ASSOCIATION BETWEEN THE INTRODUCTION OF A NEW CYSTIC FIBROSIS INHALED ANTIBIOTIC CLASS AND CHANGE IN PREVALENCE OF PATIENTS RECEIVING MULTIPLE INHALED ANTIBIOTIC CLASSES
  af: Dasenbrook, Elliott C., et al.
  Udgivet: (2014)